Biotech Leaders, Investors Urge FDA to Keep Mifepristone Access
Biotech Executives and Investors Urge FDA to Preserve Access to Mifepristone Amid Legal Uncertainty A group of leading biotechnology executives, investors, and scientific experts are urging the U.S. Food and…
Regeneron Wins FDA Nod for Myeloma Drug, Unlocks $600M Potential
Regeneron Secures FDA Accelerated Approval for Lynozyfic in Multiple Myeloma, Eyes Differentiation Despite Market Head Start by Rivals In a bid to strengthen its oncology portfolio, Regeneron Pharmaceuticals announced Wednesday…
Kennedy Adopts RSV Guidance From ACIP Panel He Dismissed
Health Secretary Robert F. Kennedy Jr. Endorses Broader RSV Vaccine Use, Following Guidance from Former ACIP Panel Despite ousting the Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel…
Actair® Promotional Activities Transition in Japan
Stallergenes Greer Appoints CEOLIA as New Promotional Partner for Actair® in Japan, Concluding 13-Year Collaboration with Shionogi Stallergenes Greer, a global leader in allergen immunotherapy, has announced a strategic transition…
WHO Reports on Role in Global Nuclear Emergency Drill
WHO Concludes Participation in Major Global Nuclear Emergency Simulation The World Health Organization (WHO) has successfully concluded its role in a high-stakes, 36-hour nuclear emergency simulation exercise organized by the…
CroíValve Secures Horizon Europe EIC Accelerator Funding
CroíValve Awarded €12.5M in Horizon Europe EIC Accelerator Funding to Advance Novel Treatment for Tricuspid Regurgitation CroíValve, a Dublin-based medical device company committed to transforming the treatment of tricuspid regurgitation…
2025 Gynecology Licensing Trends Report: 150+ Deals by Company, Therapy & Tech
Comprehensive Report Reveals Key Trends in Gynecology Collaboration and Licensing Deals from 2016 to 2025 Gynecology Collaboration and Licensing Deals report offers a deep dive into the evolving landscape of…
Synedgen Names Dr. Laura Saward CEO, Dr. Kenton Gregory CMO
Synedgen Appoints Dr. Laura Saward as CEO and Dr. Kenton Gregory as CMO Amid Strategic Growth Synedgen, Inc., a biotechnology company pioneering treatments based on human glycobiology, has announced significant…
Dyadic International Rebrands as Dyadic Applied BioSolutions
Dyadic International Rebrands as Dyadic Applied BioSolutions, Marking Strategic Shift Toward Commercial Bioprocessing Solutions Dyadic International, Inc. (Nasdaq: DYAI), a global biotechnology company known for its proprietary gene expression platforms,…
Biosynth Opens New Bioconjugation Suite in Berlin
Biosynth Unveils Expanded GMP Bioconjugation Facility in Berlin to Advance Next-Generation Therapeutics Biosynth, a global leader in providing essential raw materials and services for the life sciences and diagnostics industries,…
Medimaps Launches Next-Gen TBS Osteo Software in Europe
Medimaps Group Launches Next-Generation TBS Osteo Software Across Europe to Revolutionize Osteoporosis Detection Medimaps Group S.A., a Swiss-based global leader in AI-powered bone health solutions, has announced the European launch…
Novocure to Present Final PANOVA-3 Data in Pancreatic Cancer at ESMO GI 2025
Novocure to Present Final PANOVA-3 Data Highlighting Pain and Quality of Life Benefits of TTFields Therapy in Pancreatic Cancer at ESMO GI 2025 Novocure (NASDAQ: NVCR) announced that it will…